Shanghai Henlius Biotech (2696.HK) Q1 2026 Earnings

20MarConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
0.62
0.71
0.8
0.9

Details

Expected EPS
0.6159403008
Actual EPS
0.8959131647999999
Surprise EPS
0.28
Surprise Percent
+45.45%

Description

Shanghai Henlius Biotech (2696.HK) has reported earnings of 0.8959131647999999 per share for Q1 2026.

0 Comments

Share your thoughts